A randomised controlled trial comparing the efficacy of withdrawing alpha blocker following initial combination therapy with dual 5 alpha reductase inhibitor (5-ARI) dutasteride compared to continuation of combination therapy in the management of benign prostatic hyperlasia /
محفوظ في:
المؤلف الرئيسي: | Krishna Kumar |
---|---|
التنسيق: | أطروحة كتاب |
اللغة: | English |
منشور في: |
Kuala Lumpur :
Universiti Kebangsaan Malaysia,
2012.
|
الموضوعات: | |
الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Comparing the effectiveness of tocotrienol rich fraction and alpha tocoferol with combination of vitamin C in the management of systemic inflammatory response syndrome (SIRS) /
بواسطة: Elmehrik, Husam Yousef
منشور في: (2013) -
Combination therapy for optimum glycaemic control : a randomized open label trial comparing rosiglitazone with combination sulphonylureas and metformin tablets in type 2 diabetes mellitus
بواسطة: Ghazali, Wan Syamimee Wan
منشور في: (2006) -
Combination of metformin and FEC (5-Fluorouracil, Epirubicin, Cyclophophasmide) chemotherapy as a potential therapy for targeting cancer stem cells in breast cancer /
بواسطة: Sian, Soo Siu
منشور في: (2015) -
The effect of voiding position on uroflowmetry findings of patients with Benign Prostatic Hyperlasia (BPH) in urology clinic, Hospital Tengku Ampuan Afzan (HTAA), Kuantan, Pahang /
بواسطة: Muhd Zaki Azre bin Redzuan
منشور في: (2016) -
Development and biochemical characterisation of novel blockers of 5-hydroxytrptamine receptors /
بواسطة: Li, Haixin
منشور في: (2001)